Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued on Wednesday. The firm set a “hold” rating on the stock.

Retractable Technologies Price Performance

Shares of NYSE RVP opened at $0.72 on Wednesday. The firm’s 50-day moving average price is $0.78 and its 200-day moving average price is $0.75. Retractable Technologies has a 1-year low of $0.56 and a 1-year high of $1.23. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $21.66 million, a P/E ratio of -1.34 and a beta of 2.08.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC boosted its position in Retractable Technologies, Inc. (NYSE:RVP) by 9.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 361,253 shares of the company’s stock after acquiring an additional 31,140 shares during the period. Renaissance Technologies LLC owned 1.21% of Retractable Technologies worth $249,000 as of its most recent SEC filing. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.